Search PDMR transactions

Notifier
Name of person with notification obligation
Liljeblad & Co Aktiebolag
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Anders Liljeblad
Position
Chairman of the Board of Directors
Initial notification
No
Amendment
Yes
Details of amendment
Korrigering av befattning och ifyllande av närstående
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Prostatype Genomics AB
Issuer´s LEI code
549300JO6MPCGPVHVU91
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant Prostatype Genomics AB TO6 SE0029529767 Exercise decrease 1,437,500 Quantity 0.00 SEK 15/09/2026 FIRST NORTH SWEDEN
Interim share Prostatype Genomics AB Interimsaktie SE0030262895 Exercise increase 1,437,500 Quantity 0.10 SEK 15/09/2026 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Prostatype Genomics AB TO6 SE0029529767 Exercise decrease 15/09/2026 FIRST NORTH SWEDEN 1,437,500 (Quantity) 0.00 SEK
Prostatype Genomics AB Interimsaktie SE0030262895 Exercise increase 15/09/2026 FIRST NORTH SWEDEN 1,437,500 (Quantity) 0.10 SEK
<< Back